The increasing concern for sustainability and progress of medical research has resulted in the emergence of a wide range of biopolymers. The biodegradability of these alternative biopolymers requires investigation prior to their application in environmental and medical systems. This Thesis describes biodegradation of poly(3-hydroxybutyrate) (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(HB-co-HV)), poly(3- hydroxyoctanoate) (PHO), poly-DL-lactide (PDLL), poly-DL-lactide-co-glycolide (PDLLG) and ethyl cellulose (EC). Polymers were buried in garden soil for in vivo biodegradation experiments and a mixed population of microbes from the soil were incubated in laboratory in vitro biodegradation experiments. In both systems the short chain length PHA???s degraded rapidly and the medium chain length PHAs and other biomaterials displayed either slow or negligible weight loss. PHB and P(HB-co-HV) copolymers degraded to T50 6.7 to 9.7 times faster in vitro than in vivo. After 380 days burial in soil PHO had lost 60 % of the original 20 mg weight, PDLL 28 % and PDLLG 35 %. Ethyl cellulose and polystyrene did not biodegrade, Polymer-microbe surface interactions were investigated. The faster degrading polymers PHB and P(HB-co-HV) attracted a higher coverage of biofilm than the slower degrading polymers PHO, PDLL and PDLLG for both the in vitro and in vivo experiments. The non-degradable polymers (EC and polystyrene) attracted no biofilm. In vitro and in vivo experiments demonstrated a positive correlation between biofilm coverage and polymer weight loss. Additionally the rougher air sides of solvent cast films attracted more biofilm than the smoother dish sides. Polymer surface changes were quantified with microscopy. Surface roughness of PHB, P(HB-co-8HV) and PHO increased during biodegradation, primarily due to an increase in the waviness component for both in vitro and in vivo degradation. In vitro methods provided a rapid mechanism for protocol development and sufficiently predicted both surface roughness changes and biofilm-biodegradation relationships in vivo. PHB and P(HB-co-8HV) were blended with the biodegradable antifouling agent 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOI or Sea Nine 211). DCOI leached slowly from the films into the soil delaying biodegradation of the films until a lower residual level of DCOI remained. Biofouling was reduced on PHA films containing DCOI.

The increasing concern for sustainability and progress of medical research has resulted in the emergence of a wide range of biopolymers. The biodegradability of these alternative biopolymers requires investigation prior to their application in environmental and medical systems. This Thesis describes biodegradation of poly(3-hydroxybutyrate) (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(HB-co-HV)), poly(3- hydroxyoctanoate) (PHO), poly-DL-lactide (PDLL), poly-DL-lactide-co-glycolide (PDLLG) and ethyl cellulose (EC). Polymers were buried in garden soil for in vivo biodegradation experiments and a mixed population of microbes from the soil were incubated in laboratory in vitro biodegradation experiments. In both systems the short chain length PHA???s degraded rapidly and the medium chain length PHAs and other biomaterials displayed either slow or negligible weight loss. PHB and P(HB-co-HV) copolymers degraded to T50 6.7 to 9.7 times faster in vitro than in vivo. After 380 days burial in soil PHO had lost 60 % of the original 20 mg weight, PDLL 28 % and PDLLG 35 %. Ethyl cellulose and polystyrene did not biodegrade, Polymer-microbe surface interactions were investigated. The faster degrading polymers PHB and P(HB-co-HV) attracted a higher coverage of biofilm than the slower degrading polymers PHO, PDLL and PDLLG for both the in vitro and in vivo experiments. The non-degradable polymers (EC and polystyrene) attracted no biofilm. In vitro and in vivo experiments demonstrated a positive correlation between biofilm coverage and polymer weight loss. Additionally the rougher air sides of solvent cast films attracted more biofilm than the smoother dish sides. Polymer surface changes were quantified with microscopy. Surface roughness of PHB, P(HB-co-8HV) and PHO increased during biodegradation, primarily due to an increase in the waviness component for both in vitro and in vivo degradation. In vitro methods provided a rapid mechanism for protocol development and sufficiently predicted both surface roughness changes and biofilm-biodegradation relationships in vivo. PHB and P(HB-co-8HV) were blended with the biodegradable antifouling agent 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOI or Sea Nine 211). DCOI leached slowly from the films into the soil delaying biodegradation of the films until a lower residual level of DCOI remained. Biofouling was reduced on PHA films containing DCOI.

Indiana University-Purdue University Indianapolis (IUPUI) / Dicalcium phosphate dihydrate (DCPD) cements have been used for bone repair due to its excellent biocompatibility and resorbability. However, DCPD cements are typically weak and brittle. To overcome these limitations, the sodium citrate used as a setting regulator and the coating of poly-L-lactide acid (PLLA) technique have been proposed in this study. The first purpose of this thesis is to develop composite PLLA/DCPD scaffolds with enhanced toughness by PLLA coating. The second purpose is to examine the biocompatibility of the scaffolds. The final purpose is to investigate the degradation behaviors of DCPD and PLLA/DCPD scaffolds. In this experiment, DCPD cements were synthesized from monocalcium phosphate monohydrate (MCPM) and 𝛽-tricalcium phosphate (𝛽 –TCP) by using deionized water and sodium citrate as liquid components. The samples were prepared with powder to liquid ratio (P/L) at 1.00, 1.25 and 1.50. To fabricate the PLLA/DCPD composite samples, DCPD samples were coated with 5 % PLLA. The samples were characterized mechanical properties, such as porosity, diametral tensile strength, and fracture energy. The mechanical properties of DCPD scaffolds with and without PLLA coating after the in vitro static degradation (day 1, week1, 4, and 6) and in vitro dynamic degradation (day 1, week 1, 2, 4, 6, and 8) were investigated by measuring their weight loss, fracture energy, and pH of phosphate buffer solution. In addition, the dog bone marrow stromal stem cells (dBMSCs) adhesion on DCPD and PLLA/DCPD composite samples were examined by scanning electron microscopy. The cell proliferation and differentiation in the medium conditioned with DCPD and PLLA/DCPD composite samples were studied by XTT (2,3-Bis(2-methoxy-4- nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt), and alkaline phosphatase (ALP) assay, respectively. The addition of sodium citrate and PLLA coating played a crucial role in improving the mechanical properties of the samples by increasing the diametral tensile strength from 0.50 ± 0.15 MPa to 2.70 ± 0.54 MPa and increasing the fracture energy from 0.76 ± 0.18 N-mm to 12.67 ± 4.97 N-mm. The DCPD and PLLA/DCPD composite samples were compatible with dBMSCs and the cells were able to proliferate and differentiate in the conditioned medium. The degradation rate of DCPD and PLLA/DCPD samples were not significant different (p > 0.05). However, the DCPD and PLLA/DCPD composite samples those used sodium citrate as a liquid component was found to degrade faster than the groups that use deionized water as liquid component